Answers are grounded in this paper and cite their sources.
Rett syndrome protein MeCP2 binds broadly to both free DNA and nucleosomes, modulating chromatin architecture and either repressing or activating gene expression. However, the mechanisms by which MeCP2 engages with nucleosomes and alters chromatin structure remain elusive. Here, we present cryo-electron microscopy structures of MeCP2-bound nucleosomes reconstituted on W601 DNA and α-satellite DNA, as models for inaccessible and accessible chromatin, respectively. We find that MeCP2 molecules bind at nucleosome SHL ± 6.5 regardless of DNA sequences through interacting with DNA gyres, immobilizing linker DNA to facilitate nucleosome condensation in W601 nucleosome. In contrast, in α-satellite nucleosome, additional MeCP2 molecules localize to SHL ± 1.5 via contacts with both DNA and H3, evicting MeCP2 at SHL ± 6.5 and leading to nucleosome unwrapping. Collectively, our findings reveal that MeCP2 exhibits distinct binding behaviors on nucleosomes compared to naked DNA, and uncover its dual-mode molecular mechanism for regulating chromatin architecture and accessibility.
No takes yet. Share an insight, caveat, or question.
Lian et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: